Atlas Trials

Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

Clinical trial NCT06325423 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06325423
Sponsor
Assiut University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Muscle-Invasive Bladder Carcinoma
Start date
2024-04-01
Primary completion
2025-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.